What does CastBio do?

It is a drug discovery startup founded in 2026 that researches and develops innovative cancer therapies using Antibody-Drug Conjugate (ADC) technology.

What are the future plans for their ADC development?

They plan to advance non-clinical development using the raised funds and begin GLP safety studies and clinical trial preparations after a targeted seed round in November 2026.

What is the J-KISS method of fundraising?

It is a method that allows startups to raise funds quickly and flexibly by deferring corporate valuation to a future round.

AI News NQ Analysis

CastBio Raises Pre-Seed Funding via J-KISS from Real Tech Fund

NQ Score 74/100

N1 Content Completeness 8

AI Summary (NQ-processed)

CastBio, an ADC drug discovery startup targeting the cancer stroma, has raised pre-seed funding via J-KISS from the Real Tech Fund managed by UntroD Capital Japan. The funds will accelerate their R&D structure and non-clinical development.

AI Analysis

Frequently Asked Questions

Q: What does CastBio do?: A: It is a drug discovery startup founded in 2026 that researches and develops innovative cancer therapies using Antibody-Drug Conjugate (ADC) technology.
Q: What are the future plans for their ADC development?: A: They plan to advance non-clinical development using the raised funds and begin GLP safety studies and clinical trial preparations after a targeted seed round in November 2026.
Q: What is the J-KISS method of fundraising?: A: It is a method that allows startups to raise funds quickly and flexibly by deferring corporate valuation to a future round.